AMENDMENT NO. 1
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://medicinespatentpool.org/uploads/2022/10/MPP-Brightgene-Nilotinib-Sublicence-Amendment-No.-1-EXECUTED.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (3)
Alternatively, you can try searching for similar contracts:
